Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Jinpu Jianfu Investment Management, commonly known as GP Healthcare, is a prominent Chinese private equity firm dedicated to the healthcare and life sciences sectors. Operating as a specialized healthcare investment arm of GP Capital, the firm focuses on identifying and supporting high-growth companies across pharmaceuticals, biotechnology, medical devices, and healthcare services. GP Healthcare manages several dedicated healthcare funds, leveraging a team of industry veterans and scientific experts to provide strategic guidance and capital to its portfolio companies. The firm plays a significant role in the Chinese healthcare ecosystem by fostering innovation and facilitating the commercialization of advanced medical technologies. Its investment strategy spans from early-stage venture capital to late-stage private equity, aiming to create long-term value for both investors and the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Jinpu Jianfu Investment Management.